ADVERSE O
REACTIONS O
Adverse O
reactions O
are O
categorized O
below O
by O
organ O
system O
and O
listed O
by O
decreasing O
severity O
. O

Gastrointestinal B-NonOSE_AE
System I-NonOSE_AE
Reactions I-NonOSE_AE
* O
1 O
. O
hepatic B-OSE_Labeled_AE
encephalopathy I-OSE_Labeled_AE
in O
patients O
with O
hepatocellular B-Not_AE_Candidate
insufficiency I-Not_AE_Candidate
* O
2 O
. O
pancreatitis B-OSE_Labeled_AE
* O
3 O
. O
jaundice B-OSE_Labeled_AE
( O
intrahepatic B-OSE_Labeled_AE
cholestatic I-OSE_Labeled_AE
jaundice I-OSE_Labeled_AE
) O
* O
4 O
. O
increased B-OSE_Labeled_AE
liver I-OSE_Labeled_AE
enzymes I-OSE_Labeled_AE
* O
5 O
. O
anorexia B-OSE_Labeled_AE
* O
6 O
. O
oral B-OSE_Labeled_AE
and O
gastric O
irritation I-OSE_Labeled_AE
* O
7 O
. O
cramping B-OSE_Labeled_AE
* O
8 O
. O
diarrhea B-OSE_Labeled_AE
* O
9 O
. O
constipation B-OSE_Labeled_AE
* O
10 O
. O
nausea B-OSE_Labeled_AE
* O
11 O
. O
vomiting B-OSE_Labeled_AE
Systemic B-NonOSE_AE
Hypersensitivity I-NonOSE_AE
Reactions I-NonOSE_AE
* O
1 O
. O
severe O
anaphylactic B-OSE_Labeled_AE
or O
anaphylactoid B-OSE_Labeled_AE
reactions I-OSE_Labeled_AE
( O
e.g O
. O

with O
shock B-OSE_Labeled_AE
) O
* O
2 O
. O
systemic B-OSE_Labeled_AE
vasculitis I-OSE_Labeled_AE
* O
3 O
. O
interstitial B-OSE_Labeled_AE
nephritis I-OSE_Labeled_AE
* O
4 O
. O
necrotizing B-OSE_Labeled_AE
angiitis I-OSE_Labeled_AE
Central B-NonOSE_AE
Nervous I-NonOSE_AE
System I-NonOSE_AE
Reactions I-NonOSE_AE
* O
1 O
. O
tinnitus B-OSE_Labeled_AE
and O
hearing B-OSE_Labeled_AE
loss I-OSE_Labeled_AE
* O
2 O
. O
paresthesias B-OSE_Labeled_AE
* O
3 O
. O
vertigo B-OSE_Labeled_AE
* O
4 O
. O
dizziness B-OSE_Labeled_AE
* O
5 O
. O
headache B-OSE_Labeled_AE
* O
6 O
. O
blurred B-OSE_Labeled_AE
vision I-OSE_Labeled_AE
* O
7 O
. O
xanthopsia B-OSE_Labeled_AE
Hematologic B-NonOSE_AE
Reactions I-NonOSE_AE
* O
1 O
. O
aplastic B-OSE_Labeled_AE
anemia I-OSE_Labeled_AE
* O
2 O
. O
thrombocytopenia B-OSE_Labeled_AE
* O
3 O
. O
agranulocytosis B-OSE_Labeled_AE
* O
4 O
. O
hemolytic B-OSE_Labeled_AE
anemia I-OSE_Labeled_AE
* O
5 O
. O
leukopenia B-OSE_Labeled_AE
* O
6 O
. O
anemia B-OSE_Labeled_AE
* O
7 O
. O
eosinophilia B-OSE_Labeled_AE
Dermatologic B-NonOSE_AE
- I-NonOSE_AE
Hypersensitivity I-NonOSE_AE
Reactions I-NonOSE_AE
* O
1 O
. O
toxic B-OSE_Labeled_AE
epidermal I-OSE_Labeled_AE
necrolysis I-OSE_Labeled_AE
* O
2 O
. O

Stevens B-OSE_Labeled_AE
- I-OSE_Labeled_AE
Johnson I-OSE_Labeled_AE
Syndrome I-OSE_Labeled_AE
* O
3 O
. O
erythema B-OSE_Labeled_AE
multiforme I-OSE_Labeled_AE
* O
4 O
. O
drug B-OSE_Labeled_AE
rash I-OSE_Labeled_AE
with I-OSE_Labeled_AE
eosinophilia I-OSE_Labeled_AE
and I-OSE_Labeled_AE
systemic I-OSE_Labeled_AE
symptoms I-OSE_Labeled_AE
* O
5 O
. O
acute B-OSE_Labeled_AE
generalized I-OSE_Labeled_AE
exanthematous I-OSE_Labeled_AE
pustulosis I-OSE_Labeled_AE
* O
6 O
. O
exfoliative B-OSE_Labeled_AE
dermatitis I-OSE_Labeled_AE
* O
7 O
. O
bullous B-OSE_Labeled_AE
pemphigoid I-OSE_Labeled_AE
* O
8 O
. O
purpura B-OSE_Labeled_AE
* O
9 O
. O
photosensitivity B-OSE_Labeled_AE
* O
10 O
. O
rash B-OSE_Labeled_AE
* O
11 O
. O
pruritis B-OSE_Labeled_AE
* O
12 O
. O
urticaria B-OSE_Labeled_AE
Cardiovascular B-NonOSE_AE
Reaction I-NonOSE_AE
* O
1 O
. O

Orthostatic B-OSE_Labeled_AE
hypotension I-OSE_Labeled_AE
may O
occur O
and O
be O
aggravated O
by O
alcohol O
, O
barbiturates O
or O
narcotics O
. O

* O
2 O
. O

Increase B-OSE_Labeled_AE
in I-OSE_Labeled_AE
cholesterol I-OSE_Labeled_AE
and O
triglyceride O
serum O
levels O
. O

Other B-NonOSE_AE
Reactions I-NonOSE_AE
* O
1 O
. O
hyperglycemia B-OSE_Labeled_AE
* O
2 O
. O
glycosuria B-OSE_Labeled_AE
* O
3 O
. O
hyperuricemia B-OSE_Labeled_AE
* O
4 O
. O
muscle B-OSE_Labeled_AE
spasm I-OSE_Labeled_AE
* O
5 O
. O
weakness B-OSE_Labeled_AE
* O
6 O
. O
restlessness B-OSE_Labeled_AE
* O
7 O
. O
urinary B-OSE_Labeled_AE
bladder I-OSE_Labeled_AE
spasm I-OSE_Labeled_AE
* O
8 O
. O
thrombophlebitis B-OSE_Labeled_AE
* O
9 O
. O
fever B-OSE_Labeled_AE
Whenever O
adverse O
reactions O
are O
moderate O
or O
severe O
, O
furosemide O
dosage O
should O
be O
reduced O
or O
therapy O
withdrawn O
. O

